Castle Biosciences, Inc. (CSTL)
39.34
-0.55
(-1.38%)
USD |
NASDAQ |
Jan 09, 16:00
39.32
-0.02
(-0.05%)
After-Hours: 20:00
Castle Biosciences Research and Development Expense (Quarterly): 12.87M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 12.30M |
| Delcath Systems, Inc. | 7.986M |
| Star Operating Cos., Inc. | -- |
| CorMedix, Inc. | 5.098M |
| CytoSorbents Corp. | 0.918M |